结果：本组盆腔淋巴结阴性患者的五年总体生存率为82 0 %，中位生存时间10 0 0月。
Results: the overall 5-year survival of the patients was 82.0% and the median survival time was 100.0 months.
患者接受了三种不同治疗方案，平均生存期10个月，三年内总体生存率是27%。
With patients receiving the three different treatments, average survival was 10 months with a 27% overall survival rate at three years.
患者接受了三种不同治疗方案，平均生存期10个月，三年内总体生存率是27%。
With patients receiving the three different treatments, average survival was 10 months with a 27% overall survival rate at three years.
应用推荐